Qr code
Wei Zhang

Supervisor of Doctorate Candidates
Supervisor of Master's Candidates

Alma Mater:University of Leeds
Degree:Doctoral Degree
School/Department:Department of Engineering Mechanics
Discipline:Engineering Mechanics. Biomechanics and Nanomechanics. Materials Physics and Chemistry
Business Address:Bldg.of Engineering Mechanics, Rm407
Contact Information:wei.zhang@dlut.edu.cn
Click: times

Open time:..

The Last Update Time:..

Current position: Home >> Scientific Research >> Paper Publications

Magnetic carbon nanotubes for self-regulating temperature hyperthermia

Hits : Praise

Indexed by:期刊论文

Date of Publication:2018-01-01


Included Journals:SCIE、EI



Page Number:11997-12003

ISSN No.:2046-2069

Abstract:Magnetic hyperthermia can enhance the anti-tumor effects of chemotherapy. As carbon nanotubes are ideal drug carriers for chemotherapy, their combination with magnetic nanoparticles provides a novel chance for multi-modal thermo-chemotherapy. Most related work focuses on attaching Fe3O4 nanoparticles on carbon nanotubes, however the hyperthermia temperature for this combination can not be self-regulated due to the high Curie temperature of Fe3O4. In this work, magnetic Zn0.54Co0.46Cr0.6Fe1.4O4 nanoparticles with low Curie temperature were attached onto carbon nanotubes to obtain the magnetic carbon nanotubes. The morphology, formation mechanism, magnetic properties, heat generation ability and cytotoxicity of the magnetic carbon nanotubes were investigated. These magnetic carbon nanotubes show a Curie temperature of 43 degrees C and a self-regulating temperature at 42.7 degrees C under clinically applied magnetic field conditions (frequency: 100 kHz, intensity: 200 Oe). The evaluation of in vitro cytotoxicity suggests no obvious toxicity effects under the concentrations of 6.25 mu g ml(-1) to 100 mu g ml(-1). This study proposed a methodology for the bespoke synthesis of magnetic carbon nanotubes with a low Curie temperature for self-regulating magnetic hyperthermia, which may be used for further research on loading drugs for multi-modal cancer therapy.